| BUY | 54.870 | Shauna Sexsmith | Have had consolidation in the drugstore area. Bringing all the cosmetics to the front of the store. This is a growth stock and has a growth stock multiple. As long as it continues to deliver good earnings growth it justifies that multiple. | 2008-08-26 | |
| HOLD | 54.750 | Kevin O'Leary | Probably one of the best managed companies in Canada. Decent yield. On the growth story he doesn't know what the next metric will be to move this up. Doesn't have enough of a yield to entice him. | 2008-08-25 | |
| BUY | 53.780 | Bruce Campbell | Have shown very resilient earnings growth. Still a footprint to expand in Canada. Outlook is still quite good. | 2008-07-30 | |
| DON'T BUY | 51.100 | Jean-Francois Tardif | Great results. Doesn’t like their high PE multiple of 21X. | 2008-07-15 | |
| Comment | 55.350 | Laura Wallace | This is the retailer she is looking at closely. Great in a difficult environment. Top quality company and top merchandiser. Likes their store layout strategy. | 2008-05-23 | |
| BUY | 54.410 | Pierre Bernard | (Market Call Minute.) | 2008-05-21 | |
| BUY | 50.150 | Bruce Campbell | On a 6 month to one year this is an economic sensitivity pick. Would like to own this one and trade it once it goes up 15%. | 2008-04-11 | |
| TOP PICK | 50.620 | Gavin Graham | The bulletproof defensive play. Same-store sales growth is running high. Building 10,000 square-foot stores so you are getting people into them. Yield of 1.7%. | 2008-04-09 | |
| TOP PICK | 50.620 | Don Lato | One of the best managed companies in Canada. Trading at relatively low multiples at about 17X-18X next year's earnings. Still lots of growth opportunity for them. | 2008-04-09 | |
| BUY | 50.040 | Bruce Campbell | Slightly disappointing over the last few months. Spiked to over $52 when they reported great numbers recently and doesn't know why it fell back. Great defensive place to hide. Lots of square footage in Canada and lots of things they can do. Expecting 15%-20% earnings growth at least for another 4 years. | 2008-02-28 | |
| DON'T BUY | 49.920 | Colin Stewart | A premier franchise in Canada. The only concern he would have is the convergence in Canada of the drug retailers and grocery retailers. At quite a premium valuation to the grocery store industry, which would give him some concern. | 2008-02-27 | |
| SELL | 50.680 | Andrew Guy, CFA | (Market Call Minute.) Great company. Bad stock. Valuation is too high. | 2008-02-06 | |
| WATCH | 47.520 | David Baskin | Has always been too expensive for him. Has been getting cheaper. Earnings are coming out in the next few days and he wants to see them before he commits a lot of capital to the deal. If the earnings are good, he is very interested in this. There is speculation that the front of the store, where the expensive stuff is sold, may be taking a little bit of a hit. | 2008-02-04 | |
| PAST TOP PICK | 47.870 | Brendan Caldwell | (A Top Pick Oct 24/07. Down 10%.) Still buying. Doesn't see the falloff as a permanent setback. Business is very sound. | 2008-02-01 | |
| SELL | 50.850 | David Burrows | (Market Call Minute.) Declining growth rate and there is concern about margins. | 2008-01-18 | |
| DON'T BUY | 50.150 | Don Vialoux | (Market Call Minute.) Technicals are still pretty negative. | 2008-01-16 | |
| TOP PICK | 53.260 | Bruce Campbell | Staples as opposed to discretionary. Good defensive growth. Good entry point. | 2007-12-31 | |
| TOP PICK | 52.650 | Ross Healey | A nice, safe, solid stock. Balance sheet keeps growing just beautifully and steadily. Very profitable. This one gives you 15% to 17% a year. | 2007-12-20 | |
| TOP PICK | 53.630 | Glenn Paradis, BA, CFA | When looking for stocks that are a defensive growth, this is the one that comes to mind. Going forward, he sees 5% same store growth, 10% square footage growth and maybe a little bit of margin expansion, so you are seeing mid teens EPS growth. You're paying roughly 2X 08, 18X 09, which is not that high of the multiple. | 2007-12-17 | |
| BUY | 54.800 | Bill Carrigan | This looks like it wants to go up. Had a scary down in July but has rallied back and had a breakout. Technical analysts like to buy early on a breakout. Money managers are probably going to be looking for stocks like this. Because of market conditions, this would be a “nervous” buy for him. | 2007-11-13 | |
| BUY | 56.010 | Don Lato | Still buying for new accounts. Just reported an excellent quarter. Consistent 15% growth in earnings. Has always traded at a premium multiple, but have some good visibility. Have about 10% of square footage marked out for the next 5 years. Just initiated a global and sourcing initiative under their new CEO. | 2007-11-08 | |
| TOP PICK | 54.700 | Brendan Caldwell | Has had such a good track record both operationally and in terms of it's price. An extremely well run business. | 2007-10-24 | |
| HOLD | 55.290 | Laura Wallace | Likes the company a lot. The stock is expensive. Would aquire more in the $50 range. | 2007-10-15 | |
| HOLD | 55.270 | Ross Healey | A definite Hold and if it dropped back $4 he might even be tempted to buy. Excellent fundamentals. | 2007-10-05 | |
| DON'T BUY | 54.550 | Chyanne Fickes | Has been a spectacular stock. Have had a recent initiative of expanding into Quebec, which could be quite profitable for them. Have really decent earnings growth in 08 and 09, but you are looking at 15% growth in a 14X PE making it fully valued to her. | 2007-10-01 | |
| HOLD | 53.020 | Peter Brieger | Has held up very well in this market. The P/E is in excess of 20, which is too expensive for him. A 1st-class company. | 2007-08-14 | |
| BUY | 51.450 | Veronika Hirsch | Always looks expensive, but they always deliver. Management feels they have 2/3 years of substantial growth ahead of them still. In a volatile market, this is a very defensive name. On her watch list. | 2007-08-01 | |
| Comment | 52.260 | John O'Connell, CFA | Has had a huge run recently. Will always be able to capture a dollar flow from large portfolios because of its liquidity. | 2007-07-31 | |
| DON'T BUY | 52.010 | Brian Acker, CA | This stark has been overpriced for quite some time. He has a model price of $44.81 giving it a -14% differential. | 2007-07-27 | |
| TOP PICK | 52.050 | Jonathen Wellum, B. Comm, B. Sc | This is a business that has strong long-term secular growth because of the pharmacy. They are also doing a wonderful job on the up-front side of the business. Margins are going up. There are aggressively growing their square footage by about 10% a year. | 2007-07-26 | |
| BUY | 51.400 | Brendan Caldwell | A tremendous Canadian growth story. Has made a nice base and should be making new highs over the next 3 to 6 months. | 2007-07-24 | |
| HOLD | 50.760 | Peter Brieger | A class act in the pharmacy and related products sector. Priced to perfection. | 2007-07-19 | |
| DON'T BUY | 51.350 | Norman Levine | Has had a great run but devaluations is too high. | 2007-07-18 | |
| DON'T BUY | 50.080 | Michael Sprung | Finding P/E multiples are pretty high for retailers at this time. This one is 22 on next year's forecast earnings. That implies they have a lot of growth going forward. The questions the potential going forward. | 2007-07-13 | |
| BUY | 48.840 | Bill Carrigan | Consumer discretionary is a sector where investors want to park money. Probably a long-term theme here. | 2007-07-10 | |
| TOP PICK | 48.760 | Bruce Campbell | Forecasted growth earnings are 20%-25%. They report on July 18, which will be the catalyst and the stock will go to $51 probably. | 2007-07-09 | |
| DON'T BUY | 48.250 | Chyanne Fickes | Stock is priced to perfection. Have never disappointed in terms of their earnings. At 24 X earnings with an 8% growth rate it is not good value. | 2007-07-05 | |
| TOP PICK | 50.160 | Bruce Campbell | Has gone sideways for a few months. One year target in high $50.
Likes the new management. | 2007-06-05 | |
| DON'T BUY | 50.390 | Peter Brieger | It's a great company, but it's fully priced and the uptrend has been broken, and you may see the stock heading down from here. | 2007-06-04 | |
| PARTIAL SELL | 50.660 | Michael Smedley | Has plateaued a bit. Worried a little bit that absolute growth has diminished. Not one of his favourites. Would take a bit of profit. | 2007-05-25 | |
| Comment | 50.580 | Laura Wallace | Looking at this one closely as a consumer discretionary stock. Excellent growth. Not cheap at 25 X earnings. | 2007-05-23 | |
| PAST TOP PICK | 50.500 | Gavin Graham | Not much of a dividend yield, but a steady growth stock. Earnings growth is 22%.
One of the primary retailers in Canada, if not North America. Still a buy at todays price. | 2007-05-22 | |
| DON'T BUY | 50.950 | Bill Carrigan | Has been in a long-term upward trend. Thinks the upward move is over. Momentum is slowing down. Thinks it's dead money and it's not going to go anywhere. | 2007-05-15 | |
| HOLD | 51.200 | Robert Floyd | Quarterly numbers were fairly good. Likes the way they are formatting their stores. Good management. Pretty steady growth. | 2007-05-11 | |
| PAST TOP PICK | 50.750 | Bruce Campbell | (A Top Pick May 31/06. Up 20.8%.) A premium Canadian growth company. Sees the growth continuing. | 2007-05-09 | |
| DON'T BUY | 51.340 | Norman Levine | Ontario government is changing how they are paying for prescriptions, which means less money for drugstores. This has now made this and expensive stock. | 2007-05-01 | |
| WAIT | 50.860 | Michael Sprung | Ontario government is talking about the way it pays for generic drugs, so the stock pulled back. He would wait and see what happens. | 2007-04-27 | |
| PAST TOP PICK | 51.500 | Richard Croft | (A Top Pick July 4/06. Up 25.8 %.) Good dividend. Strong Company. | 2007-04-26 | |
| BUY | 50.500 | Robert Floyd | Trying to merge into other types of shopping such as groceries that have low margins. They are still plugging ahead and doing it fairly good job of it. | 2007-04-19 | |
| PAST TOP PICK | 51.150 | Bruce Campbell | (A Top Pick May 31/06. UP 21.8%.) Had recommended on valuation and growth. Can see 15% to 18% growth for 3-4 years. | 2007-04-02 | |
| BUY | 50.900 | Gavin Graham | Probably the best Canadian retailer. It always looks expensive. Dividend of 1.25% is growing consistently. Good management. | 2007-03-26 | |
| DON'T BUY | 50.490 | Laura Wallace | Likes this, but a little too expensive here. Impressive growth strategies. Would consider at $45. | 2007-03-14 | |
| Comment | 51.050 | Brendan Caldwell | Has been a really consistent performing company. Until you begin to see the stock flattening out or fall over, it is one that will continue to go up and pay a decent dividend. | 2007-02-27 | |
| HOLD | 52.370 | Michael Decter | Sold his holdings mid-$40’s, where he thought it was fully valued. He was wrong. One of the great Canadian brands. Brilliant strategy. As a value investor, he always feels it is a little pricey. He thinks it will keep going. | 2007-02-26 | |
| BUY | 52.020 | David Cockfield | High multiple, but they do a great job. Have really carved a market niche for themselves. | 2007-02-23 | |
| DON'T BUY | 53.270 | Peter Brieger | A superbly run company. Priced to perfection at 23 X forward earnings. Too rich for him. | 2007-02-19 | |
| TOP PICK | 52.710 | Stephen Carlin | In the Canadian retail section, this and Tim Hortons (THI-T) are the crème de la crème. Perennially expensive, but they just keep delivering. 15% earnings growth, year in, year out. | 2007-02-14 | |
| DON'T BUY | 50.220 | John Zechner | Sold his holdings at about this level. It has been a really good story and expects it to grow at a similar rate. He is a little uncomfortable with its high multiple in the mid-20’s. Also had a change in management. There are some pricing pressures coming in. | 2007-01-22 | |
| BUY | 50.110 | Robert Floyd | Likes this company. Reasonable growth rate. Seems to be chugging along quite nicely. | 2007-01-03 | |
| DON'T BUY | 49.720 | Chyanne Fickes | Stiffer competition in the market right now. Wal-Mart is starting to dispense pharmacies at reduced rates in the US and they could eventually do this in Canada. Expecting to have a 14% sales growth next year and is trading at 22 X earnings. A bit pricey. | 2006-12-18 | |
| BUY on WEAKNESS | 50.840 | Rob Callander | Keeps growing, expanding their stores, bringing in new product lines, strong year-over-year sales gains. | 2006-11-23 | |
| BUY | 50.390 | Michael Smedley | A blue-chip company. Investors are moving to the high quality. Moving more into cosmetics. | 2006-11-22 | |
| HOLD | 47.750 | Robert Floyd | Reported some very good numbers. Gaining market share on the pharmacy side. Should see higher highs. | 2006-11-13 | |
| WAIT | 45.440 | Laura Wallace | Great company. A little expensive at this time. A defensive stock. Wait for a lower price. Would prefer $40. | 2006-10-24 | |
| PAST TOP PICK | 45.000 | Bruce Campbell | (A Top Pick Aug 18/05. Up 9.1%.) Good defensive growth. Was surprised it wasn't higher. Would buy at this price. | 2006-10-05 | |
| DON'T BUY | 45.570 | Chyanne Fickes | She presently does not own but tried to buy this stock at $40.00 in the summer. Recommends not buying at this price. Believes it is overpriced. | 2006-10-02 | |
| BUY | 46.490 | David Burrows | Based on economic sensitivity, this company is in the right group. Premier retailer in Canada right now. Had solid growth in earnings last 2 quarters. | 2006-09-13 | |
| PAST TOP PICK | 46.410 | Bruce Campbell | (A Top Pick July 5/06. Up 13%.) Was undervalued when he picked it. Still likes. | 2006-09-11 | |
| BUY | 46.410 | Ian Nakamoto | Good defensive play. Will continue to grow. The demographics are good. Their health and beauty aids is a high margin business. | 2006-09-11 | |
| HOLD | 46.200 | Norman Levine | A defensive stock. When the economy turns down, people still go in to drugstores. It is also a growth stock. From a valuation point of view, it might be fully priced, up from a technical point of view it may have broken out. | 2006-09-05 | |
| TOP PICK | 46.640 | Martin Hubbes, CFA | Not cheap, but the earnings visibility is wonderful. Lots more room for growth of new stores as well as revamping what they have and driving more sales per square foot. Relatively safe in an economic downturn. | 2006-09-01 | |
| DON'T BUY | 46.630 | Brian Acker, CA | His model price is $37.02, a 20% negative differential. Very expensive. The model price has been going down somewhat. | 2006-08-31 | |
| WEAK BUY | 45.840 | Veronika Hirsch | Fantastically managed. A stock that people go into as a defence, the way they used to go into Loblaws (L-T). Expensive, but expect it will get more expensive. | 2006-08-29 | |
| PAST TOP PICK | 45.720 | Bruce Campbell | (A Top Pick Aug 18/05. Up 8.8%.) Was a pick because the growth was going that are but the stock wasn't doing much. Finally, in the last few weeks, there has been a strong recovery. | 2006-08-25 | |
| BUY | 44.620 | Norman Levine | A good time to be in defensive plays and this one would fit in that category. Not a high dividend yielding stock, but the shares should do well. | 2006-08-22 | |
| TOP PICK | 44.510 | Jonathen Wellum, B. Comm, B. Sc | Management is focused, Canadian marketplace, run efficiently. Half the revenue is from the pharmacy, which is a big competitive advantage for them. They are adding 10% square footage growth every year over the next seven years. Beauty/cosmetics is a big business with high margins. | 2006-08-17 | |
| SELL | 44.400 | David Cockfield | Looks a little expensive on a multiple basis. He has taken some profits recently. Dividend is minimal and he thinks the market will punish low dividend stocks. | 2006-08-16 | |
| WATCH | 44.210 | Peter Brieger | Expensive at 20/22 X earnings. Earnings are up 17 to 18% next year over this year. Try to buy in the $40/$42 range. | 2006-08-09 | |
| BUY | 44.660 | Ian Nakamoto | This is a “go to” stock for a defensive play. An excellent franchise. Continues to increase sales per square foot. | 2006-08-03 | |
| BUY | 44.000 | John Zechner | Earnings just came out and they had a good quarter. Continue to deliver on the earnings growth. Can see growth at 12/15% over 3 to 4 years at least. A defensive sector. | 2006-07-31 | |
| TOP PICK | 45.000 | Fred Pynn | Same store sales growth is attractive. Continues to add square footage. No hint of competition coming from the US. Great locations. | 2006-07-26 | |
| BUY | 44.000 | Laura Wallace | Excellent defensive play. Just reported quarterly earnings that were superb. Lagging in part because of the drug bill Ontario is passing. Will have less impact than expected. Trades at a discount to its peers in the US with significantly higher margins. | 2006-07-20 | |
| BUY | 40.400 | Gavin Graham | Off about 8.5% and down about 1% over the last year. 1.2% yield. The premier drug company in Canada. If you want pharmaceuticals, this is what you should buy. Good price. | 2006-07-06 | |
| TOP PICK | 40.600 | Bruce Campbell | Has growth and is relatively safe. Pulled back on concerns of Bill 102, but risks have been disseminated so it will mean nothing or a penny or two of earnings. | 2006-07-05 | |
| TOP PICK | 40.930 | Richard Croft | Pays 1.17%. The largest pharma presence in Canada. Have done a lot of refurbishing of their stores. A good defensive play. Has had a good correction. | 2006-07-04 | |
| BUY | 41.950 | Neil Wickham | A core stock. Good performance. Should grow at 15/25% per year in earnings and cash flow. | 2006-06-20 | |
| BUY | 42.130 | David Burrows | In a defensive part of the market. In general, drug stores and the like should do well if the market is slowing down. Prefers Alimentation Couche-Tard (ATD.B-T) but this one should do well. | 2006-06-15 | |
| TOP PICK | 42.900 | Gavin Graham | A low risk way to play the ageing baby boomers, drug stores are the way the go. A well-run company. The high multiple can be justified because they will continue to execute extremely well. | 2006-06-12 | |
| DON'T BUY | 42.140 | Veronika Hirsch | Ontario government is passing Bill 102 which will give generic drugs some leverage. This won't slow their growth although it will affect their earnings. An incredibly expensive stock. | 2006-06-01 | |
| TOP PICK | 42.000 | Bruce Campbell | The P/E multiple on forward earnings is about 17 which is as cheap as it has been for quite a while. Looking for 20% growth. Lots of store rollout still. Down because the Ontario government is looking into the treatment of generic drugs. | 2006-05-31 | |
| DON'T BUY | 43.960 | Brian Acker, CA | This one is always expensive to him. Great company with great fundamentals but is not a mis-priced asset. His model price is $39.50 which is a negative 10% differential. | 2006-04-27 | |
| BUY | 44.380 | John Zechner | Probably have six to eight years of double-digit earnings growth in front of it. | 2006-04-26 | |
| BUY on WEAKNESS | 45.130 | Laura Wallace | Keeping a close eye on this one. Part of it is in the consumer discretionary area which she is a little bit cautious on. A great company. Good square footage growth. Would like to buy it at $40. | 2006-04-10 | |
| BUY | 45.900 | Gavin Graham | Continue to execute well. Demographics look wonderful. Continuing to expand. Continue to raise their dividends. | 2006-03-20 | |
| HOLD | 44.970 | Bruce Campbell | Likes it below $40 it's half way to his target of $50. So it's a hold right now. A really solid company. | 2006-03-06 | |
| TOP PICK | 44.400 | Peter Gibson | ROE growth will likely drive the stock to new levels. This should weather the coming correction. (April May timeframe) | 2006-02-20 | |
| DON'T BUY | 44.000 | Norman Levine | A great company, but fully valued at this price. | 2006-02-13 | |
| HOLD | 44.000 | Laura Wallace | The big risk is that a lot of their products are consumer discretionary. If interest rates stay up and housing prices come down, consumer discretionary products are vulnerable. However, this is an extraordinary well-run company that continues to gain market share. | 2006-02-07 | |
| BUY | 42.600 | Ian Nakamoto | This is the way to play the pharmaceutical sector. Buy it and hold it. | 2006-01-31 | |
| BUY | 43.000 | Ross Healey | Has been bouncing along pretty well all year at 4 X book value. Fall back to good technical support at $40 and has now had a nice jump of about 10%. Has decent upside potential but the stock doesn’t seem to want to move out of its range. Give it 5/10% upside and then sell if you want to treat it as a trade. | 2005-12-13 | |
Experts that have talked about Shoppers Drug Mart Corp
Rss Top Picks Feed
